US doubles COVID vaccine fund as Moderna enters final phase of clinical trial
The United States has doubled its investment to nearly $1 billion to expedite development of a potential COVID-19 vaccine by...
The United States has doubled its investment to nearly $1 billion to expedite development of a potential COVID-19 vaccine by...
Arctoris Ltd. supports global research efforts to find new therapeutics against COVID-19. Scientists in academic centres and companies around the...
Cytel Inc., an advanced analytics leader providing sophisticated quantitative insights to decision-makers in clinical investigation, has announced the launch of...
Pfizer Inc. and BioNTech SE announced an agreement with the United Kingdom to supply 30 million doses of their BNT162...
Allergan, an AbbVie company, announced that the U.S. FDA approved a supplemental Biologics License Application (sBLA) that supports expanded use...
Amgen announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary shares, which maintains Amgen's...
AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that Lynparza (olaparib) has been approved in the European Union (EU) for...
AstraZeneca’s heart failure drug Farxiga has picked up a US FDA fast-track designation (FTD) in another indication as it continues...
Boehringer Ingelheim announced that the EC has approved an additional indication for nintedanib in adults for the treatment of other...
IDEAYA Biosciences Inc, an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced that it...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.